Trevena Reports Third Quarter 2014 Financial Results and Provides a Corporate Update Nov 11, 2014 7:00am EST
Trevena Announces Early Completion of Enrollment of Phase 2a/b Study of TRV130 in Postoperative Pain Oct 08, 2014 7:00am EDT
Trevena CEO to Present at the Canaccord Genuity 34th Annual Growth Conference Aug 07, 2014 4:19pm EDT
Trevena Initiates Phase 1 Multiple Ascending Dose Study of TRV734 for Acute and Chronic Pain Aug 06, 2014 7:00am EDT
Trevena to Host Conference Call to Discuss Second Quarter 2014 Results on August 12 Aug 05, 2014 7:00am EDT
